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Abstract
The human gut harbors a complex ecosystem of
microorganisms, including bacteria and viruses. With
the rise of next-generation sequencing technologies,
we have seen a quantum leap in the study of human-
gut-inhabiting bacteria, yet the viruses that infect
these bacteria, known as bacteriophages, remain
underexplored. In this review, we focus on what is
known about the role of bacteriophages in human
health and the technical challenges involved in
studying the gut virome, of which they are a major
component. Lastly, we discuss what can be learned
from studies of bacteriophages in other ecosystems.
Introduction to the virome
With an estimated population of 1031, viruses are the most
numerous biological entities on Earth, inhabiting diverse
environments ranging from the oceans to hydrothermal
vents to the human body [1]. The human body is inhab-
ited by both prokaryotic (mostly bacterial) and eukaryotic
(mostly human) viruses. Researchers have historically fo-
cused on eukaryotic viruses because of their well-known
impact on human health, including the influenza virus
that causes seasonal flu epidemics and the viruses that
cause devastating health consequences like HIV and
Ebola. However, increasing evidence suggests that pro-
karyotic viruses can also impact human health by affecting
the structure and function of the bacterial communities
that symbiotically interact with humans [2, 3]. The viruses
that infect bacteria, called bacteriophages, can play a key
role in shaping community structure and function in
ecosystems with high bacterial abundance [4, 5] such as
the human gut.
In recent years viruses have gained their own “-ome”
and “-omics”: the virome and (meta)viromics. These terms
encompass all viruses inhabiting an ecosystem along with
their genomes and the study of them, respectively. These
viruses can be classified in many ways including on the
basis of their host (Fig. 1). In this review we focus on bac-
teriophages, mainly in the human gut ecosystem, and dis-
cuss their role in human health. We then lay out the
challenges associated with the study of the gut virome,
the existing solutions to these challenges, and the les-
sons that can be learned from other ecosystems.
Bacteriophages: dynamic players in ecosystems
Bacteriophages are the most abundant group of viruses
and are obligatory parasites propagating in bacterial
hosts. The potential host range is phage-specific and can
vary from only one bacterial strain to multiple bacterial
species. During infection, a bacteriophage attaches to the
bacterium surface and inserts its own genetic material
into the cell. The bacteriophage then follows one of two
main life cycles: a lytic cycle or a lysogenic cycle.
Lytic cycles are lethal to host cells and culminate in
the production of new phages. Well-known examples of
viruses with lytic cycles are the T7 and Mu phages that
mainly infect Escherichia coli. These phages initially hi-
jack the bacterial cell machinery to produce virions.
Thereafter, the bacterial cell is lysed, releasing 100–200
virions into the surrounding environment where they
can infect new bacterial cells. They can thus play an im-
portant role in regulating the abundance of their host
bacteria.
In contrast, a lysogenic cycle refers to phage replica-
tion that does not directly result in virion production.
A temperate phage is a phage that has the ability to
display lysogenic cycles. Under certain conditions, such
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as DNA damage and low nutrient conditions, these
phages can spontaneously extract themselves from the
host genome and enter the lytic cycle [7]. This exci-
sion, called induction, may occur with the capture of
specific parts of the bacterial genome. The ability of
phages to transfer genes from one bacterium to an-
other by means of lysogenic conversion or transduc-
tion (as reviewed in [8]) can lead to increased
diversification of viral species and of their associated
bacterial host species. These phenomena may cause
the spread of toxins, virulence genes, and possibly anti-
biotic resistance genes through a bacterial population
[8]. A well-known example of temperate phage is the
phage CTXφ of Vibrio cholera that alters the virulence
of its bacterial host by incorporating the genes that
code for the toxin that induces diarrhea [9]. Phages
may thus serve as important reservoirs and transmit-
ters of genetic diversity. The classification of phages
based on their life cycle is a topic of much debate [10]
and variations of life cycles like pseudolysogeny and
carrier-states have been proposed [11, 12].
In the human gut ecosystem, temperate bacteriophages
dominate over lytic bacteriophages [13–15]. It is believed
that the majority of bacterial cells have at least one phage
inserted into their genome, the so-called prophage. Some
prophages may be incorporated in bacterial genomes for
millions of generations, losing their ability to excise from
host genomes because of genetic erosion (degradation and
deletion processes) [16]. These prophages, which are
called cryptic or defective, have been shown to be import-
ant for the fitness of the bacterial host [17] and thus repre-
sent an essential part of a bacterial genome.
Major hallmarks of the human gut virome
The human gut virome develops rapidly after birth
During early development, the virome, like the bacter-
iome, is extremely dynamic [18–20]. In 2008 Breitbart
et al., using direct epifluorescent microscopy, concluded
that meconium (earliest infant stool) contained no
phages [21]. Just 1 week later the infant stool contained
108 viral-like particles (VLPs) per gram of feces [21].
Similar to the bacteriome, the infant virome was found
to be less diverse than that of adults [21]. The exact
mechanism of the origin of phages in the infant gut has
yet to be identified, although one hypothesis could be
that the phages arise as a result of the induction of pro-
phages from gut bacteria. Numerous other factors are
also thought to shape the infant gut virome, including
environmental exposures, diet, host genetics, and mode
of delivery [15, 19, 20]. McCann et al. compared the
virome of infants born via vaginal delivery to that of in-
fants born via cesarean delivery and found that the
alpha- and beta-diversity of the infant virome differed
significantly between birth modes [19]. The authors were
able to identify 32 contigs that were differentially abun-
dant by birth mode, including several contigs bearing
high levels of nucleotide homology to Bifidobacteria
temperate phages. This was thought to reflect differen-
tial colonization by Bifidobacterium with birth mode.
Furthermore, an increased abundance of the vertebrate
ssDNA virus Anelloviridae was found in infants born via
vaginal delivery, suggesting its vertical transmission from
mother to baby [19]. The abundance of this virus had
previously been shown to decrease after the age of 15
months [15], but it nonetheless remains highly prevalent
in humans worldwide [22]. Diet may also play a role in
colonization of infant gut, as Pannaraj et al. showed that
a significant proportion of bacteriophages were trans-
ferred from mothers to infants through breast milk [23].
Despite these interesting results, only a few studies to
date have investigated the infant virome longitudinally.
In 2015, Lim et al. conducted a longitudinal study of the
virome and bacteriome in four twin pairs, from birth to
2 years, and found that the expansion of the bacteriome
with age was accompanied by a contraction and shift in
the bacteriophage composition [20].
The human gut virome consists mostly of bacteriophages
As in other environments, bacteriophages dominate over
other viruses in the gut ecosystem. Transmission elec-
tron microscopy has shown that the human gut virome
consists mostly of DNA bacteriophages from the order
Caudovirales along with members of Myoviridae, Podo-
viridae, and Siphoviridae families (Fig. 2) [27, 30].
Recently, the order Caudovirales was expanded to in-
clude Ackermannviridae and Herelleviridae [31]. In
addition, CrAssphage has been found to be a prevalent
constituent of the human gut microbiome, possibly
representing a new viral family (Fig. 2) [28, 32, 33]. This
phage was recently found to be present in thousands of
human-feces-associated environments around the world,
Fig. 1 Viruses can be classified based on various characteristics.
These terms are used continuously throughout this manuscript.
While all characters are important in determining taxonomic
relationships, sequence comparisons using both pairwise sequence
similarity and phylogenetic relationships have become one of the
primary sets of characters used to define and distinguish virus
taxa [6]
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confirming it as a strong marker for fecal contamination
[34]. Highly divergent but fully colinear genome se-
quences from a few crAss-like candidate genera have
been identified in all major groups of primates, suggest-
ing that crAssphage has had a stable genome structure
for millions of years [34]. This in turn suggests that the
genome structure of some phages can be remarkably
conserved in the stable environment provided by the hu-
man gut [34]. The abundance of eukaryotic viruses in
the human gut is low, however, some studies report that
small amounts are present in every faecal sample [35,
36]. These amounts increase dramatically during viral
gastrointestinal infections [14, 37–39].
The human gut virome is temporally stable in each
individual but shows large inter-individual diversity
A study by Minot et al. showed that approximately 80%
of the phages in a healthy adult male were maintained
over a period of 2.5 years (the entire duration of their
study) [26]. This was recently also demonstrated by
Shkoporov et al., who found that assemblies of the same
or very closely related viral strains persist for as long as
26 months [40]. This compositional stability was further
reflected in stable levels of alpha-diversity and total viral
counts, suggesting that viral populations are not subject
to periodic fluctuations [40]. In a longitudinal study
where six individuals were exposed to a short-term fat-
and fiber-controlled dietary intervention, the gut virome
was shown to be relatively stable in each individual [14].
The same study also showed that interpersonal variation
in the gut virome was the largest source of variance,
even among individuals following the same diet [14].
The large inter-individual variations in the virome are
consistent with those seen in the bacteriome and appear
largely due to environmental rather than genetic factors.
It was recently shown in a cohort of monozygotic twins
that co-twins did not share more virotypes than unre-
lated individuals and that bacteriome diversity predicts
viral diversity [41].
Interaction of the human gut virome with the
bacteriome in relation to health
In recent years, numerous associations have been estab-
lished between the human intestinal bacteriome and a
number of diseases, syndromes, and traits [42]. Support
for these associations varies from anecdotal reports
from individuals to results from large cohort studies.
For example, in their large cohort study, Falony et al.
found the core bacterial microbiome (i.e., the genera
shared by 95% of samples) to be composed of 17 genera
with a median core abundance of 72.20% [43]. Other
studies have shown that a large percentage of the gut
bacteriome is represented by members of the Firmicutes
and Bacteroidetes, and that their relative levels change in
individuals with conditions such as obesity, inflammatory
bowel disease (IBD), and diabetes [44–46]. This suggests
the existence of a “healthy” bacteriome that is disrupted in
disease.
In recent years there have also been attempts to
characterize a “healthy gut phageome”. In 2016, Manri-
que et al. used ultra-deep sequencing to study the
Fig. 2 Size distributions of genomes and virions of the most prevalent virus families in the gut. Values are given for the prototype virus of each
family. Prokaryotic viruses are shown in red, eukaryotic viruses in blue. Structural information as well as genome sizes have been exported from
the ICTV Online Report [24]. The prevalence of each family in the human gut has been inferred from the following studies: Inoviridae [20, 25],
Circoviridae, Adenoviridae, Microviridae, Podoviridae, Myoviridae, Siphoviridae [26], Anelloviridae [25–27], CrAss-like [28, 29]. dsDNA double-stranded
DNA. ssDNA single-stranded DNA
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presence of completely assembled genomes of phages in
64 healthy people around the world [47]. The authors
proposed that the phageome could be split into three
parts: i) the core, which is composed of at least 23 bacte-
riophages, one of them crAssphage, found in > 50% of all
individuals; (ii) the common, which is shared among 20–
50% of individuals; and (iii) the low overlap/unique,
which is found in a small number of individuals. The lat-
ter fraction represented the majority of found bacterio-
phages in the whole dataset [47]. This study, amongst
others, suggests that a core virome should not be deter-
mined as strictly as the core bacteriome has thus far
been defined. Therefore, crAssphage, the abundance of
which was not associated with any health-related vari-
ables, is likely to be a core element of the normal human
virome [34].
An attractive model to study bacteria–phage interac-
tions is through the use of gnotobiotic mice, which are
colonized with a limited collection of bacteria that are
well characterized yet still complex [48]. Recently, Hsu
et al. colonized gnotobiotic mice with a defined set of
human gut commensal bacteria and subjected them to
predation by cognate lytic phages [49]. This revealed
that phage predation not only directly impacted suscep-
tible bacteria, but also led to cascading effects on other
bacterial species via interbacterial interactions [49]. Fecal
metabolomics in these mice revealed that phage preda-
tion in the mouse gut microbiota can potentially impact
the mammalian host by changing the levels of key me-
tabolites involved in important functions such as gastric
mobility and ileal contraction [49].
Bacteriophages and disease
The high inter-individual variability of the virome in
healthy individuals presents a challenge for disease asso-
ciation studies, but even with this challenge, compelling
evidence is emerging for bacteriophage involvement in
several diseases (Table 1). For example, in a study com-
paring individuals with IBD to household controls, IBD
patients had a significant expansion of the taxonomic
richness of bacteriophages from the order Caudovirales
[52]. Cornault et al. found that prophages of Faecalibac-
terium prausnitzii, a bacterium usually depleted in indi-
viduals with IBD, are either more prevalent or more
Table 1 Selection of studies on gut virome changes in humans in various disease states
Disease Study population Major finding Authors
Malnutrition Healthy twins (n = 8 pairs) versus twins discordant
for severe malnutrition (n = 12 pairs)
Bacteriophage as well as members of the Anelloviridae and
Circoviridae families of eukaryotic viruses discriminate






CDI patients (n = 24) versus healthy controls (n =
20)
Treatment response in FMT associated with a high colonization
level of donor-derived Caudovirales taxa in the recipient. Caudo-






Crohn’s disease (n = 16) and ulcerative colitis (n =
36) and household controls (n = 21)
Enteric virome richness was increased in Crohn’s disease and
ulcerative colitis, and both forms of IBD were associated with a






CRC cases (n = 74) and controls without CRC (n =
92) in Hong Kong. Validated in three independent
European cohorts
Dysbiosis of the gut virome was associated with early- and late-
stage CRC. A combination of four taxonomic markers was asso-







HIV-negative (n = 40), treatment naïve (n = 40),
and treated HIV patients (n = 40) in Uganda
Alterations in the enteric virome and bacterial microbiome
were associated with low peripheral CD4 T cell counts rather






11 infants from Finland and Estonia recruited at
birth based on their HLA risk genotype and
followed for 36 months
Significant enrichment of Circoviridae-related sequences in
samples from controls in comparison with cases. Higher







T2D patients (n = 71) and non-diabetic Chinese
adults (n = 74), validated in independent cohort
Observed a significant increase in the number of gut phages in
the T2D group and identified seven phage operational
taxonomic units specific to T2D. Significant alterations of the




Hypertension Healthy controls (n = 41), pre-hypertension (n =
56), and hypertension patients (n = 99) in China
Noted that certain viruses can be selected as biomarkers to
distinguish healthy people, pre-hypertension people, and
hypertension patients. Viruses had superior resolution and bet-






PD patients (n = 31) and control individuals (n =
28)
Identified shifts of the phage/bacteria ratio in lactic acid
bacteria known to produce dopamine and regulate intestinal
permeability, both major factors implicated in PD pathogenesis
Tetz et al.
2018 [58]
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abundant in the fecal samples of IBD patients compared
to healthy controls, suggesting that these phages might
play a role in the disease pathophysiology [59]. This sup-
ports the importance of studying the virome concur-
rently with the bacteriome in order to obtain a holistic
picture of the gut ecosystem changes in a disease like
IBD. Nor is this relationship between IBD and virome
limited to human studies. Duerkop et al. [60] reported
that, in murine colitis, intestinal phage communities
undergo compositional shifts similar to those observed
by Norman et al. in human IBD patients [52]. Specific-
ally, Duerkop et al. observed a decrease in phage com-
munity diversity and an expansion of subsets of phages
in animals with colitis. Furthermore, Clostridiales phages
were decreased during colitis, and the authors suggested
that members of the Spounaviridae subfamily of phages
could serve as informative markers for colitis [60].
It is important to keep in mind that, although many
diseases show associations with various bacteriophages,
it is extremely hard to establish causality. Furthermore,
in these association studies it is difficult to establish
whether alterations in the microbiome and virome are a
cause or a consequence of the disease. Koch’s postulates
are a set of criteria designed to establish a causative rela-
tionship between a microbe and a disease. In 2012,
Mokili et al. proposed a metagenomic version of Koch’s
postulates [61]. In order to fulfill these metagenomic
Koch’s postulates, the following conditions must be met:
i) the metagenomic traits in diseased subjects must be
significantly different from those in healthy subjects; ii)
the inoculation of samples from a diseased animal into a
healthy control must lead to the induction of the disease
state; and iii) the inoculation of the suspected purified
traits into a healthy animal will induce disease if the
traits form the etiology of the disease [61]. Many studies
investigating the role of specific bacteriophages in hu-
man disease have been able to fulfill the first criterion
and have found significant differences in viral contigs or
specific phages between diseased and healthy individuals
(Table 1). However, only a few of these studies are
supported by animal experiments, and most of these ex-
periments are in the form of fecal microbiota transplant-
ation (FMT) rather than delivery of specific inoculated
phages [62, 63]. Furthermore, the question of causality
becomes even more complex when, as is often the case,
multiple phages are likely to be involved in the etiology
of a disease (Table 1).
It is known that both the gut virome and gut micro-
biome can be pathologically altered in patients with
recurrent Clostridium difficile infection [64], and FMT
has rapidly become accepted as a viable and effective
treatment [65]. Ott et al. described the greater efficacy of
bacteria-free fecal filtrate transfer compared to FMT in
reduction of symptoms in patients with C. difficile
infection [66]. The filtrate recovered from normal stool
contains a complex of bacteriophages, as shown by ana-
lysis of VLPs from the filtrate, which suggests that
phages may mediate the beneficial effects of FMT [66],
although this could also be the effect of various
metabolites.
Interestingly, phages can also directly influence human
immunity. Recent research has shown phages to modu-
late both human innate and adaptive immunity
(reviewed in [67]). One way in which phages can directly
influence host immunity was described by Barr et al. as
the Bacteriophage Adherence to Mucus model (BAM)
[3]. In BAM, phages adhering to mucus reduce bacterial
colonization of these surfaces, thereby protecting them
from infection and disease [3].
Since their discovery in the early twentieth century,
lytic bacteriophages have been seen to have promising
potential as antimicrobial agents, although this potential
was broadly surpassed by the rapid development of anti-
biotics as our main antibacterial agents. Currently, the
applications of lytic bacteriophages go far beyond their
antimicrobial activity as they are now engineered as ve-
hicles for drug delivery and vaccines [68, 69] and broadly
used in molecular biology and microbiology [70, 71].
In recent years there have been some attempts to sys-
tematically study the effect of phages in trial settings.
Yen et al. showed that prophylactic administration of a
Vibrio cholerae-specific phage cocktail protects against
cholera by reducing both colonization and cholera-like
diarrhea in infant murine and rabbit models [72]. In
contrast, Sarker et al. showed that oral coliphages,
though safe for use in children suffering from acute bac-
terial diarrhea, failed to achieve intestinal amplification
and improve diarrhea outcome [73]. This was possibly
due to insufficient phage coverage and too low E. coli
pathogen titers, meaning that higher oral phage doses
were probably required to achieve the desired effect [73].
These studies demonstrate how bacteriophage therapy is
still in its infancy despite its long use in the field of med-
ical sciences [74–76] and emphasize the need for more
systematic fundamental in vitro studies, translational
animal studies, and large, properly controlled, random-
ized controlled trials.
Studying the human gut virome
The extensive study of the bacteriome that has been tak-
ing place over the past few years may partly be due to
the presence of universal phylogenetic markers such as
the 16S rRNA gene. In contrast to bacteria, viruses lack
such a universal marker. Studying the virome therefore
requires large-scale metagenomic sequencing (MGS)
approaches (Fig. 3). However, there are numerous chal-
lenges to be overcome in the process of viral MGS data
generation and analysis. Below we outline and discuss
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the common challenges in widely used methods of
studying the virome, as well as their possible solutions.
A summary of the challenges of virome studies and the
approaches to tackle them are outlined in Table 2.
Sample collection and storage
The first challenge in gut-microbiome-related studies is
the limited number of samples an individual can provide,
particularly in the framework of biobanks and large-
scale studies. Moreover, in low biomass samples such as
viral communities from certain environmental ecosys-
tems and human-related specimens, researchers need to
be extremely careful of environmental contamination
from kits and reagents [105].
Post-sampling, bacteria and bacteriophages remain in
contact with each other and will continue having
ecological interactions, which means that prolonged
incubation of samples at room temperature can affect
the ratio of microbes to the point that they are no lon-
ger representative of in situ conditions [78]. Overcom-
ing this issue requires extracting viral genetic material
immediately after collection (if possible) or rapidly
freezing samples at − 80 °C.
Nucleic acid extraction
Similar to gut microbiome studies, gut virome studies
begin by isolating the genetic material from intestinal
specimens (Fig. 3). Given the perceived predominance of
DNA viruses in human stool [14, 15], current virome
studies mainly use DNA extraction from fecal samples
[78–80]. However, the current conception of gut virome
composition might underestimate the abundance of
RNA viruses. For example, RNase I is commonly used in
VLP isolation protocols to remove free capsid-
unprotected RNA of non-viral origin [78, 79]. However,
RNase I has recently also been shown to affect the RNA-
fraction of the virome [84]. To get a true estimate of the
RNA viruses in the sample, one needs to restrict the use
of RNase I, although this might come at a cost of in-
creased contamination (Table 2).
The main hurdle in studying the virome, however, is
the parasitic nature of bacteriophages. Their ability to be
incorporated into the host bacterial genome causes the
Fig. 3 The steps in metagenomic study of the virome. Nucleic acid extraction: the virome can be studied by extraction of nucleic acids from both
fractions of the total microbial community which includes bacteria and viruses (left) and purified viral-like particles (VLPs; right), and different types
of VLP-enriching techniques might be applied to obtain the latter fraction (see main text for details). Genomic library preparation: the extracted
viral genetic material is subjected to sequencing after genomic library preparation. Both the choice of genomic library preparation technique and
the sequencing coverage can affect the representation of specific members of the viral community in the sample (see discussion in the main
text). Quality control: the raw sequencing reads are further trimmed of sequencing adapters, and low-quality and overrepresented reads are
discarded. Virome annotation: there are two main ways of studying viral communities—read-mapping to closed reference databases or de novo
assembly of viral genomes with optional, but advised, validation of contigs via reference databases
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Table 2 Challenges of studying human gut virome and possible solutions




• Existence of active and silent fractions of viromes
• Total nucleic acid isolation protocols (TNAI):
+ Allow characterization of microbiome along with virome potential =
holistic picture of all components of the microbiome
+ High-throughput
– Lead to inflation of false-positive hits from bacteria in the subsequent
data analysis
• Viral-like particle (VLP) isolation protocols:
+ Ensure true positives on viruses due to physical removal of bacteria
by filtration
– Give a low-concentration output [79] that may complicate the
genomic library preparation step
– Usually require multiple time-consuming steps of VLP and nucleic
acid precipitation [78, 80]





• Limited amount of viral genetic material available • Use of more sensitive genomic library preparation kits
• MDA may lead to overrepresentation of circular ssDNA viruses [82]
and underrepresentation of viruses with extreme GC content [83]
• Restricted use of MDA
• Studying RNA viruses requires additional effort due to the relative
instability of RNA genetic material:
- Use of reverse transcriptase to convert RNA to cDNA
- Restricted usage of RNase in protocols handling both DNA and
RNA viruses [84]
- May require separate isolation protocol (arising from the previous
point) and, therefore, increase of the starting material
• Metatranscriptomics approaches
• Use of reverse transcription step
• Studying ssDNA viruses requires additional effort:
- Some of the WGA techniques that precede the genomic library
preparation procedure might introduce biases into the representation
of ssDNA viruses [77, 82, 85]
- The majority of current genomic library preparation procedures
cannot handle ssDNA genomes due to the use of dsDNA adapters
- ssDNA viruses have been shown to have higher mutation rates
than dsDNA viruses [86], thus increasing the microdiversity of the
metagenome, which limits reference-based approach
• Use of ssDNA adaptors in adaptor-ligation reaction at
the genomic library preparation step [77]
• Selection of an appropriate cut-off for coverage is complicated • Studies report discoveries of a huge number of viruses
at a depth of 1–15 × 106 reads per sample [60, 78–80]
Quality
control
• Removal of bacterial sequences is complicated by the viral signals
from prophages (both cryptic and inducible) carried by bacterial
genomes
• Use of tools for identification of prophages in bacterial
genomes [87–89], though some are limited to known
prophages. The combination of multiple methods has
been shown to enrich the set of detected prophages




• Existing databases do not fully represent viral diversity [91] • Use of de novo assembly approaches
• Rapid evolution and diversity of viral genomes limits
reference-based approaches
• Use of reference databases that include both cultured
viruses and computationally identified viral
contigs [25, 92]
• Use of a protein-based search
• Use of a profile hidden Markov model based on protein
domains allows the identification of remote homologs
[93]
• De novo assembly approach is sensitive to biases introduced during
genomic library preparation and sequencing:
- Low DNA input for genomic library preparation decreases the
percentage of reads that map back to the corresponding assemblies
[94, 95]
- Use of a DNA amplification step might affect the distribution
of read coverage [94, 96]
- Shifts in GC content during genomic library preparation
[97] affect the completeness of genomes and cause assembly fragmentation
• Adjustment of the assembly pipeline according to
applied genomic library preparation procedure [96]: use
of modes suitable for an uneven distribution of read
coverage such as single-cell SPAdes
[98, 99] preceded by read de-duplication [96] or
Velvet-SC [100]
• Use of genomic library preparation protocols without
any amplification procedure (needs high DNA input,
probably not applicable for viromics) [101, 102]
• Reproducibility of assembly results when combining different assemblers is
complicated by technical challenges [103, 104] and the possibility of the
appearance of chimera assemblies [104]
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nominal division of the virome into active (lytic phages)
and silent (prophages) fractions (Table 2). Depending on
the targeted fraction of the virome, DNA extraction pro-
tocols may differ substantially. For instance, the active
virome is primarily studied through the extraction of
DNA from VLPs obtained by filtration, various chemical
precipitations [14, 15, 29, 47], and/or (ultra)centrifuga-
tion [106, 107]. In contrast to studying the active virome,
the concurrent targeting of both the silent and active
virome (so-called “virome potential”) requires total nu-
cleic acid isolation (TNAI) from all the bacteria and vi-
ruses in the sample [56–58]. While both approaches
have their pros and cons (Table 2), a combination of
both is desirable, albeit expensive, because this will give
the complete picture of the microbiome communities.
In addition to the exclusion of RNA viruses during the
isolation of genetic material in some common extraction
protocols, ssDNA viruses might also be overlooked. Se-
quencing of ssDNA virus genomes is difficult because of
the limited number of genomic library preparation kits
that allow in situ representation of ssDNA viruses with-
out amplification bias (Table 2) [77]. Thus, the current
conception that the gut virome is predominantly com-
posed of dsDNA viruses might be biased by the relative
ease of processing dsDNA.
Genomic library preparation
At the step of preparation of genomic libraries, low viral
biomass poses a new challenge since many existing gen-
omic library preparation kits require inputs of up to mi-
crograms of DNA, amounts that are rarely available for
virome samples. Taking into account the perceived pre-
dominance of bacteriophages in human stool (see “Major
hallmarks of the human gut virome” section), the typical
input amount of DNA after the extraction step can be es-
timated as follows: the number of bacteriophages in 1 g of
human feces is 109 [108–110] and the average genome
size of a bacteriophage is 40 kbp [111] (Fig. 2), so the total
amount of bacteriophage DNA in 1 g of human feces is
40 ∙ 109 kbp with the weight of 43.6 ng. Thus, depending
on the elution volume (usually 50–200 μl), any VLP isola-
tion protocol for stool will result in a minuscule concen-
tration of bacteriophage DNA: [0.22–0.87] ng/μl. This is
also the range observed in the benchmarking of VLP ex-
traction protocols, although with variations that can reach
an order of magnitude in some cases [78–80]. Therefore,
the application of more sensitive kits that enable the hand-
ling of nano- and picograms of DNA input [77] or whole-
(meta)genome amplification (WGA) is needed (Table 2).
Although WGA has been shown to be a powerful tool for
studying the human gut virome [19, 20], some WGA tech-
niques, even non-PCR-based methods such as multiple
displacement amplification (MDA), unevenly amplify lin-
ear genome fragments and might introduce biases into the
representation of ssDNA circular viruses [82, 85]. There-
fore, in the presence of MDA, the downstream analysis of
viral community composition might be limited to
presence-absence statistics because relative abundances
might be biased towards specific viruses. Another type of
WGA, adaptase-linker amplification (A-LA), is preferable
for studying differentially abundant viruses since it keeps
them quantifiable and allows unbiased representation
[77]. Moreover, A-LA allows the study of both ssDNA
and dsDNA viruses compared to other quantitative WGA
methods such as alternative linker amplification (LA) and
tagmentation (TAG), which are mostly focused on dsDNA
viruses [77, 85].
At the sequencing step, the selection of a coverage
cut-off poses an additional challenge (Table 2). In gen-
eral, as a very complex and diverse community, the vir-
ome requires ultra-deep sequencing [47], even though
such sequencing might also complicate downstream ana-
lysis [112]. Generally, the increase of coverage leads to
an increase in the number of duplicated reads with se-
quencing errors. These duplicated reads might align to
each other and create spurious contigs that prevent as-
sembly of longer contigs [112, 113].
Quality control
After overcoming the barriers faced in isolation and se-
quencing of virome communities, new challenges need
to be overcome in the data analysis. Initially, it is neces-
sary to discard human-host and bacterial-host reads that
may introduce biases into the virome community profil-
ing. While there are now many tools that remove nearly
all human-related reads, filtering of bacterial reads may
be challenging due to the presence of prophages within
bacterial genomes. As inducible and cryptic prophages
are important players in the gut ecosystem [16, 17], it is
necessary to filter bacterial reads carefully since they
may contain prophage genome sequences that should be
taken into consideration during the virome analysis.
There are now several tools that can identify prophage
sequences in MGS data (Table 2).
Data analysis
Sequencing reads passing quality control are thereafter
subjected to virome profiling. Currently, there are two
general strategies for virome profiling based on MGS
data: (i) reference-based read mapping and (ii) de novo
assembly-based profiling (Fig. 3). Both strategies face
challenges in the characterization of viral community
(Table 2). The reference-based read mapping approach,
which is the one broadly used in microbiome studies, is
limited by a scarcity of annotated viral genomes [114].
However, the enormous viral diversity and viral genetic
microdiversity will also complicate de novo assembly of
metagenomes [115, 116] (Table 2).
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Rapid evolution, an innate feature of viruses that allow
them to inhabit almost every ecological niche, leads to
substantial intraspecies divergence [117]. Although the
human gut virome has been shown to be stable over
time, partly due to the temperate character of the major-
ity of human gut viruses, some members of the human
gut virome can evolve quickly. For example, it has been
shown for lytic ssDNA bacteriophages from Microviri-
dae inhabiting the human gut that a 2.5-year period is
sufficient time for a new viral species to evolve [26]. This
may limit the use of reference-based approaches in
studying the virome, although some studies have suc-
cessfully used this method for virome annotation in
combination with the de novo assembly-based method
[55, 118] (Table 2).
The de novo assembly of metagenomes that was success-
fully used for the discovery of CrAssphage [28] does not
rely on the reference databases. Therefore, de novo
assembly-based approaches give a more comprehensive es-
timation of the complexity of viral communities and viral
dark matter (uncharacterized metagenomic sequences ori-
ginating from viruses) (Fig. 3) [119]. However, metagenome
assembly outcome is highly dependent on the read cover-
age [113] since the default assembly workflow assumes an
even coverage distribution for each genome [99]. Some
biases introduced during sample processing might affect
the coverage distribution and therefore hamper de novo as-
sembly in terms of completeness of genomes and assembly
fragmentation. The sources of such bias include low DNA
input for genomic library preparation [94, 95], use of A-LA
[94, 96], and shifted GC content associated with MDA [97].
In addition, it has been shown that the choice of sequen-
cing technology has a minimal effect on the de novo assem-
bly outcome [95], while the choice of assembly software
crucially affects results [104] (Table 2).
Regardless of the method chosen for virome anno-
tation, more challenges come at the step of taxonomy
assignment to viral sequences. Currently, only 5560
viral species have been described and deposited with
the International Committee on Taxonomy of Vi-
ruses (ICTV) [31]. Despite the rapid growth of the
ICTV database after it allowed the deposition of de
novo assembled viral sequences that were not cul-
tured or imaged [120] and the application of gene-
sharing networks to viral sequences for taxonomy as-
signment [121], levels above genus are still unavail-
able for many known viruses. Nonetheless, there are
reasons to be optimistic. The ICTV committee re-
cently decided to expand the taxonomical classifica-
tion of viruses to levels above rank and order [122],
and the first-ever viral phylum [123] has already been
reported. More higher-order ranks can be expected
given the rise of pace and uniformity of novel viral
genomes deposited [124].
Lessons from other ecosystems
Fortunately, the majority of the technical challenges de-
scribed in Table 2 have already been addressed in stud-
ies of viral communities in other human organs (such as
skin [125, 126] and lungs [127]) and in environmental
ecosystems (such as seawater [128, 129] and soil [130]).
Some of the solutions from environmental studies are
now being applied to similar challenges in the human
gut (Table 2). However, we still need a systematic ap-
proach to studying the gut virome as a complex commu-
nity. Environmental studies have a long history of taking
the entire complex community into account: from the
sequencing of the first viral metagenome of an ocean
sample in 2002 [131] to the 2019 global ocean survey
that revealed almost 200,000 viral populations [132].
This is in striking contrast to human-oriented studies,
which have often been limited to the identification of
specific pathogens in order to combat them. Given this
historical context, additional analytical approaches and
hypotheses developed in cutting-edge viral ecogenomic
studies of environmental samples might also be applic-
able to the human gut virome.
Many environmental studies have benefited from
the use of multi-omics approaches [81, 116, 133]. For
example, Emerson et al. showed the potential of bac-
teriophages to influence complex carbon degradation
in the context of climate change [81]. This has been
possible partially due to the advantages of metatran-
scriptomics and the concurrent reconstruction of bac-
terial and viral genomes from soil metagenomics [81].
Additionally, combining metaproteomic and metage-
nomic approaches has identified highly abundant viral
capsid proteins from the ocean, and these proteins
may represent the most abundant biological entity on
Earth [133].
Next to these multi-omic approaches, viral metage-
nomic assembly can be complemented by single-virus
genomics (SVG), which includes individual sequencing
of the genome of the viruses once each viral particle has
been isolated and amplified. Therefore, unlike de novo
assembly of metagenomes, de novo assembly of SVG ge-
nomes can address viral genetic microdiversity and
thereby enable the reconstruction of more complete viral
genomes [116]. SVG has identified highly abundant mar-
ine viral species that have, so far, not been found via
metagenomic assembly [116]. These newly identified
viral species possess proteins homologous to the afore-
mentioned abundant capsid proteins, confirming their
widespread presence in oceans [133]. Furthermore, an-
other challenge of de novo assembly—the presence of
low coverage regions—might be overcome through the
use of long-read sequencing (> 800 kbp), which was re-
cently shown to recover some complete viral genomes
from aquatic samples [134].
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In addition to the advances in data generation from
viral communities, approaches to overcoming the
problem of dominance of unknown sequences in viral
metagenomes have been suggested in several environ-
mental studies. Brum et al. used full-length similarity
clustering of the proteins predicted from viral genomic
sequences to reveal the set of core viral genes shared
by samples originating from seven oceans, the diver-
sity patterns of marine viral populations, and the eco-
logical drivers structuring these populations [135].
Taking into account the huge inter-individual vari-
ation of the human gut virome (see “Major hallmarks
of the human gut virome” section), it might be useful
to use a similar approach to identify the core viral
genes in the human gut.
To understand the mechanisms behind the phage–
host interaction in the context of the gut ecosystem, it
might also be useful to use viral-encoded auxiliary meta-
bolic genes (AMGs). The analysis of AMGs and their
abundance in marine samples facilitated the identifica-
tion of the role of bacteriophages in nitrogen and sulfur
cycling by affecting the host metabolism [136]. Further-
more, the study of viral communities in the polar region
of the Southern Ocean highlighted the value of AMG
analysis in understanding how lytic and temperate
phages survive during seasonal changes in their bacterial
host abundance, which follows the availability of nutri-
ent resources [137]. Another approach applied by Zeig-
ler Allen et al. in the study of the marine microbiome
community suggests using bacteriophage sequence sig-
natures, together with measures of the virus/bacteria ra-
tio and bacterial diversity, to evaluate the influence of
viruses on the bacterial community instead of direct
comparison of co-abundance profiles [138]. This method
redefined the viral infection potential and confirmed the
role of bacteriophages in shaping the entire marine com-
munity structure.
Similarly, in soil ecosystems, where bacteria dominate
over archaea and eukaryotes as they do in marine ecosys-
tems, it has been shown that phages play an important
role in defining ecosystem composition and function [81,
130, 139]. Moreover, in ecosystems such as anaerobic di-
gesters, more than 40% of the total variation of the pro-
karyotic community composition is explained by the
presence of certain phages, and this is much higher than
the explanatory potential of abiotic factors (14.5%) [140].
Studies in plants have also demonstrated that phages are a
major factor influencing bacterial composition [141].
However, the applicability of these findings to the human
gut, which is also a bacteria-dominated ecosystem, has yet
to be explored.
It is important to bear in mind that ecological con-
cepts from one ecosystem might have limited applic-
ability to another. Even if two ecosystems have similar
viral community structures, the underlying ecological
relationships may differ. For example, a predominance
of temperate viruses was reported in a polar aquatic re-
gion [137]. This predominance of temperate phages
corresponds to that in the gut ecosystem. However, for
the polar marine ecosystem, it was shown that temper-
ate phages switch from lysogeny to lytic infection mode
with the rise of bacterial abundance [137]. This is
opposite to the Piggyback-the-Winner model observed
in the human gut, where temperate phages dominate
over lytic phages when the bacterial host is abundant
[142, 143]. This difference in ecological concepts be-
tween the gut and distinct marine ecosystem reflects
the exposure to different factors of the environment.
The polar aquatic region has a periodic nature owing to
the change of seasons, while the gut ecosystem can be
considered relatively stable (see “Major hallmarks of
the human gut virome” section). Therefore, while hu-
man gut viromics might benefit from considering some
cutting-edge approaches developed in environmental
studies, caution should be exercised in extrapolating
ecological concepts found in distinct ecosystems to sit-
uations pertaining to the human gut.
Concluding remarks
Given the fascinating and challenging nature of vi-
ruses, emerging evidence for the role of gut bacterio-
phages in health and disease and on-going paradigm
shifts in our understanding of the role of certain vi-
ruses in other ecosystems, the further development of
viromics is much warranted. Once we have overcome
the current challenges of gut virome research, for ex-
ample, through optimization of virome isolation pro-
tocols and expansion of the current databases of
(un)cultivated viruses, future directions for develop-
ment in the study of the human gut virome will be:
(i) to establish a core gut virome and/or core set of
viral genes through the use of large longitudinal co-
hort studies; (ii) to study the long-term evolution of
bacteriome–virome interactions under the influence
of external factors; and (iii) to establish the causality
of the correlations with host-related phenotypes
through the use of model systems, multi-omics ap-
proaches, and novel bioinformatic techniques, possibly
including those inherited from environmental studies.
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